Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Carl Zeiss Meditec AG ADR News

    106,40 $ -1,16% -1,25 $
    In : 99,196 € | 25.04.24 21:45:08 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0YGQ7
    ISIN: US14218T1051
    US-Symbol: CZMWY
    Typ: Aktie

    Carl Zeiss Meditec AG ADR News

    04.04.24 - PR Newswire
    Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
    Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire
    04.04.24 - PR Newswire
    Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market
    Carl Zeiss Meditec AG Completes Acquisition of Dutch Ophthalmic Research Center (D.O.R.C.); Companies Unite to Shape Ophthalmology Market PR Newswire
    28.03.24 - PR Newswire
    ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
    ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 PR Newswire
    28.03.24 - PR Newswire
    ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024
    ZEISS Sets Stage for Future of Ophthalmic Surgery and 3D Visualization at ASCRS 2024 PR Newswire
    11.01.24 - PR Newswire
    U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
    U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS PR Newswire
    11.01.24 - PR Newswire
    U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
    U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS PR Newswire
    15.12.23 - PR Newswire
    Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
    Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.) PR Newswire
    23.10.18 - PR Newswire
    Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery
    Carl Zeiss Meditec to Acquire IanTECH, Inc. to expand its portfolio in cataract surgery PR Newswire
    05.10.18 - PR Newswire
    ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism
    ZEISS Receives FDA Approval for ReLEx SMILE, Expanding Myopia Treatment to Patients with Astigmatism Small Incision Lenticule Extraction, better known as ReLEx SMILE from ...
    21.09.18 - PR Newswire
    ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
    ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide PR Newswire
    21.09.18 - PR Newswire
    ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide
    ZEISS establishes the patented SMILE technology with 1.5 million laser vision corrections worldwide ZEISS announces two new milestones in refractive technology, with 1.5 million ...
    21.09.18 - PR Newswire
    ZEISS Presents Integrated Data-Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way
    ZEISS Presents Integrated Data-​Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way PR Newswire
    21.09.18 - PR Newswire
    ZEISS Presents Integrated Data-Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way
    ZEISS Presents Integrated Data-​Driven Digital Solutions at ESCRS, Advancing Eye Care for Patients Every Step of the Way PR Newswire
    04.11.15 - PR Newswire
    ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery
    ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery PR Newswire
    04.11.15 - PR Newswire
    ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery
    ZEISS Introduces OPMI PENTERO 800 to Reconstructive Surgery PR Newswire
    02.12.13 - PR Newswire
    New Breast Cancer Study Results Published in The Lancet Compare Targeted Radiotherapy During Surgery With ZEISS INTRABEAM to Traditional Post-Surgical Radiotherapy Treatment
    New Breast Cancer Study Results Published in The Lancet Compare Targeted Radiotherapy During Surgery With ZEISS INTRABEAM to Traditional Post-​Surgical Radiotherapy ...

    Newssuche

    Videos

    newspaper
    25.04.24 +21,95%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »